How Supply Chain Resilience Mediates Between the Impact of Blockchain Technologies on Sustainable Supply Chain Performance

The pharmaceutical sector has been and continues to be challenged by unprecedented challenges in disruption, counterfeit medications, and now was pressured about higher sustainability standards. This paper evaluated the effects of Blockchain Technology Adoption (BTA) and its effects on Sustainable Supply Chain Performance (SSCP) of pharmaceutical manufacturing, through a mediating effect of Supply Chain Resiliency (SCR). The paper creates a conceptual model using Resource-Based View (RBV) That characterizes blockchain as a digital strategic asset that enhances the firm's ability to withstand shocks and create long-term sustainability. A quantitative research method was applied using data from pharmaceutical manufacturing firms to examine the proposed relationships. The data collected from non-probability sample of pharmaceutical companies in Sudan, the questionnaires distributed to managers and supervisors working in pharmaceutical manufacturing companies The results suggested blockchain technology had a significant direct effect on Sustainable Supply Chain Performance